Chondroitin

MK2-IN-1 hydrochloride is a potent and selecitve MAPKAPK2(MK2) inhibitor(IC50=0.11 uM) with a non-ATP competitive binding mode.IC50 value: 0.11 uM Target: MAPKAPK2(MK2) inhibitorMK2-IN-1 was profiled for kinase selectivity by screening against a

MK2-IN-1 hydrochloride is a potent and selecitve MAPKAPK2(MK2) inhibitor(IC50=0.11 uM) with a non-ATP competitive binding mode.IC50 value: 0.11 uM Target: MAPKAPK2(MK2) inhibitorMK2-IN-1 was profiled for kinase selectivity by screening against a

MK2-IN-1 hydrochloride is a potent and selecitve MAPKAPK2(MK2) inhibitor(IC50=0.11 uM) with a non-ATP competitive binding mode.IC50 value: 0.11 uM Target: MAPKAPK2(MK2) inhibitorMK2-IN-1 was profiled for kinase selectivity by screening against a

MK2-IN-1 hydrochloride is a potent and selecitve MAPKAPK2(MK2) inhibitor(IC50=0.11 uM) with a non-ATP competitive binding mode.IC50 value: 0.11 uM Target: MAPKAPK2(MK2) inhibitorMK2-IN-1 was profiled for kinase selectivity by screening against a

General description This gene encodes a protein similar to the mouse hedgehog-interacting protein, a regulatory component of the hedgehog signalling pathway. Members of the hedgehog family are evolutionarily conserved proteins which are involved

A disulfide dimer of N-acetylcysteine with immunomodulatory and anti-atherosclerotic properties modifies contact sensitivity/delayed hypersensitivity reactions in mice and improves endothelial function in Watanabe heritable hyperlipidemic rabbits.

A disulfide dimer of N-acetylcysteine with immunomodulatory and anti-atherosclerotic properties modifies contact sensitivity/delayed hypersensitivity reactions in mice and improves endothelial function in Watanabe heritable hyperlipidemic rabbits.

A bacterial-derived pentapeptide that irreversibly inhibits aspartic proteases, including pepsin, gastricsin, renin, cathepsin E, and cathepsin D examined as a therapeutic agent for inflammatory conditions including gastric ulcer, edema, and

A bacterial-derived pentapeptide that irreversibly inhibits aspartic proteases, including pepsin, gastricsin, renin, cathepsin E, and cathepsin D examined as a therapeutic agent for inflammatory conditions including gastric ulcer, edema, and

A bacterial-derived pentapeptide that irreversibly inhibits aspartic proteases, including pepsin, gastricsin, renin, cathepsin E, and cathepsin D examined as a therapeutic agent for inflammatory conditions including gastric ulcer, edema, and

A bacterial-derived pentapeptide that irreversibly inhibits aspartic proteases, including pepsin, gastricsin, renin, cathepsin E, and cathepsin D examined as a therapeutic agent for inflammatory conditions including gastric ulcer, edema, and

PrEST Antigen CHODL chondrolectin, 100ul UN 1687 6.1 PG2